This website uses cookies.

By clicking the "Accept" button or continuing to browse our site, you agree to first-party and session-only cookies being stored on your device to enhance site navigation and analyze site performance and traffic. For more information on our use of cookies, please see our Privacy Policy.

  1. Home
  2. Journals
  3. American Economic Journal: Economic Policy
  4. Forthcoming Articles
  5. Competitive Bidding in Drug Procurement: Evidence from China

Competitive Bidding in Drug Procurement: Evidence from China

  • Shengmao Cao
  • Lisa Xuejie Yi
  • Chuan Yu
American Economic Journal: Economic Policy (Forthcoming)

Abstract

We study the equilibrium effects of introducing competitive bidding in drug procurement. In 2019, China introduced a competitive bidding program where drug companies bid for a prespecified procurement quantity in nine provinces. Using a difference-in-differences design, we show that the program reduced average drug prices by 47.4%. Generic drugs won most bids and cut prices by 75.0%. We develop an equilibrium model to quantify the trade-off between lower prices and potential choice distortions. Competitive bidding increases consumer welfare if policymakers believe consumers should value branded and bioequivalent generic drugs equally. The program also reduced government expenditure on insurance by 19.8%.

Downloads